Increased Soluble CD137 Levels and CD4+ T-Cell-Associated Expression of CD137 in Acute Atherothrombotic Stroke.

In addition, five stroke patients receiving statin therapy demonstrated a decreasing trend of plasma sCD137 levels at 3 and 14 days posttreatment ( Figure 4 ), as these patients appeared to have higher baseline sCD137 levels (3.3 pg/ml (range: 2.9–5.6) than the rest of the population.

also in 47,180 other papers